Experimental Drug Raises Hopes In COVID-19 Fight

Photo: Mr Hyde at Czech / Wikipedia

App users, tap here to watch video report.

WASHINGTON – There’s new hope in the search for a drug to treat the Coronavirus as researchers work toward a vaccine.








It’s called Remdesivir, a drug in initially intended to treat the Ebola virus. That application wasn’t fruitful, but there are signs that Remdesivir may be useful in reducing the lethality and severity of the Coronavirus.

In preliminary results of this new study sponsored by the National Institutes of Health, more than 1,000 patients were randomly assigned to take either Remdesivir or a placebo.









It took the placebo patients 15 days to recover. It took the Remdesivir patients 11 days to recover, a 31% improvement. Specifically, the drug blocks an enzyme the virus needs to replicate. Researchers can use that knowledge to create other drugs.

Although, researchers are clear: this is not by any means a cure for Coronavirus.















 

Make it easy to keep up to date with more stories like this. Download the WNY News Now mobile app on the Apple App Store and Google Play Store.

 

Have a news tip? Email newsdesk@WNYNewsNow.com, send us a message on Facebook, or Twitter.

WNY News Now encourages an open exchange of opinions and ideas on our stories, however, we ask everyone to follow our comment policy.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.